BDA 1.06% 46.5¢ bod australia limited

Bod’s exclusive partner, iX Biopharma, secures China patent for...

ANNOUNCEMENT SPONSORED BY PLUS500
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM
CFD Service. Your Capital is at risk
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
  1. 620 Posts.
    lightbulb Created with Sketch. 26
    Bod’s exclusive partner, iX Biopharma, secures China patent for drug delivery technology
    • Bod’s cannabis wafer product now patent protected in China and other key Asian markets
    • iX Biopharma awarded patents in over 20 countries – Provides Bod with significant international
    expansion opportunities
    • Key Daigou relationships already in place – sales to commence following the granting of necessary
    regulatory approvals
    • Clinical trials process progressing well – significant developments made recently with
    commencement pending
    ------------
    Steady progress being made here IMO.
    MC only $25m (tight register).
    Management have significant skin in the game.
 
watchlist Created with Sketch. Add BDA (ASX) to my watchlist

Currently unlisted public company.

arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.